This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Imaging carotid body chemodectomas with 68Ga-DOTA-NOC PET-CT
- Novel SDHD Gene Mutation (H102R) in a Patient With Metastatic Cervical Paraganglioma Effectively Treated by Peptide Receptor Radionuclide Therapy
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- Clinical aspects of SDHx-related pheochromocytoma and paraganglioma
- 111In-Octreotide Is Superior to 123I-Metaiodobenzylguanidine for Scintigraphic Detection of Head and Neck Paragangliomas
- Superiority of Fluorodeoxyglucose Positron Emission Tomography to Other Functional Imaging Techniques in the Evaluation of Metastatic SDHB-Associated Pheochromocytoma and Paraganglioma
- Effects of Therapy with [177Lu-DOTA0, Tyr3]Octreotate in Patients with Paraganglioma, Meningioma, Small Cell Lung Carcinoma, and Melanoma
- Clinical Impact of Somatostatin Receptor Scintigraphy in the Management of Paragangliomas of the Head and Neck
- Peptide Receptor Imaging and Therapy
- Intraosseous Paraganglioma of the Sacrum: A Case Report